Part,  Chapter, Paragraph

  1    I,     2.  4    |                causes of death, including cardiovascular disease, many cancers, and
  2    I,     2.  4    |             faster mortality declines for cardiovascular diseases. In many Western
  3    I,     2.  4    |               substantial improvements in cardiovascular disease mortality. This
  4    I,     2.  5    |        work-related stress also increases cardiovascular mortality (Finnish Heart
  5    I,     2.  5    |              stress, which also increases cardiovascular mortality. In industrialised
  6    I,     2.  5    |                times increase the risk of cardiovascular diseases.~ ~Pension provision.
  7    I,     2. 10.  2|                  and uses in oncology and cardiovascular medicine. Currently, there
  8   II,     5.  1.  1|           mortality and morbidity include cardiovascular diseases; cancer; asthma
  9   II,     5.  1.  1|              income developing countries, cardiovascular complications and neoplasia
 10   II,     5.  1.  1|              Figure 5.1.1a. Proportion of cardiovascular disease, cancer and violence (
 11   II,     5.  1.  1|              Figure 5.1.1b. Proportion of cardiovascular disease, cancer and violence (
 12   II,     5.  1.  1|                 non-communicable diseases~Cardiovascular diseases~CVD clinically
 13   II,     5.  2    |                                      5.2. Cardiovascular diseases~ ~
 14   II,     5.  2.Acr|              Computed Tomography Scan~CVD~Cardiovascular Disease~DBP~Diastolic Blood
 15   II,     5.  2.Acr|                  events~EUROCISS~European Cardiovascular Indicators Surveillance
 16   II,     5.  2.Acr|                trends and determinants of CArdiovascular diseases~WHO-HFA~World Health
 17   II,     5.  2.  1|                  women die from stroke.~ ~Cardiovascular disease (CVD) accounts for
 18   II,     5.  2.  2|                trends and determinants of Cardiovascular disease (WHO MONICA) (ht /,
 19   II,     5.  2.  2|               EUROCISS Project - European Cardiovascular Indicators Surveillance
 20   II,     5.  2.  2|                since 1950; the changes in cardiovascular and all-cause mortality
 21   II,     5.  2.  2|               EUROCISS Project - European Cardiovascular Indicators Surveillance
 22   II,     5.  2.  3|                 to the 1990s. Since then, cardiovascular mortality started to decrease
 23   II,     5.  2.  5|                   June 2004) on promoting cardiovascular health, emphasize the importance
 24   II,     5.  2.  5|              Presidency note on promoting cardiovascular health in the Health Council
 25   II,     5.  2.  6|            diagnostic technologies in the cardiovascular field have facilitated diagnosis
 26   II,     5.  2.  6|                1996). Blood pressure as a cardiovascular risk factor: prevention
 27   II,     5.  2.  6| blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed
 28   II,     5.  2.  6|                   pressure on the risk of cardiovascular disease. N Engl J Med 345:
 29   II,     5.  2.  7|                 Rayner M (2008): European cardiovascular disease statistics. EHN:
 30   II,     5.  2.  7|                   et al (2004): Favorable Cardiovascular Risk Profile in Young Women
 31   II,     5.  2.  7|               Women and Long-term Risk of Cardiovascular and All-Cause Mortality
 32   II,     5.  2.  7|                    Lubitz J et al (2005): Cardiovascular risk profile earlier in
 33   II,     5.  2.  7|                 2006. European Journal of Cardiovascular Prevention & Rehabilitation.~
 34   II,     5.  2.  7|                   et al (2006): Favorable cardiovascular risk profile (Low Risk)
 35   II,     5.  2.  7|                    European guidelines on cardiovascular disease prevention in clinical
 36   II,     5.  2.  7|                 and Attributable Risks of Cardiovascular Disease Incidence in Relation
 37   II,     5.  2.  7|            Kromhout D (2006): Dynamics of cardiovascular and all-cause mortality
 38   II,     5.  2.  7|               Stamler J (2006): Favorable cardiovascular risk profile and 10-year
 39   II,     5.  2.  7|                   mass reduction to lower cardiovascular risk: The Italian Progetto
 40   II,     5.  2.  7|                   Gray A (2005): European cardiovascular disease statistics. BHF:
 41   II,     5.  2.  7|                   heart disease and other cardiovascular diseases in 27 countries,
 42   II,     5.  2.  7|                   long-term prevention of cardiovascular diseases. Bulletin of the
 43   II,     5.  2.  7|               Force (1997): The burden of cardiovascular diseases mortality in Europe.
 44   II,     5.  2.  7|                  Society of Cardiology on Cardiovascular mortality and morbidity
 45   II,     5.  2.  7|                  blood pressure and other cardiovascular risk factors explain trends
 46   II,     5.  2.  7|                trends and determinants in cardiovascular disease. Lancet 353:1547-
 47   II,     5.  2.  7|                  Pisa Z (1988): Trends in cardiovascular disease mortality in industrialized
 48   II,     5.  4.  1|             neuropathy) and in particular cardiovascular disease contribute to high
 49   II,     5.  4.  1|               miscarriage and stillbirth.~Cardiovascular complications: Long lasting
 50   II,     5.  4.  2|                  in persons with diabetes~Cardiovascular mortality in patients with
 51   II,     5.  4.  6|           guaranteed. Type 2 diabetes and cardiovascular disease share many risk
 52   II,     5.  5.Int|              almost all studies15.~ ~Only cardiovascular disease has a greater toll
 53   II,     5.  5.  3|              accidents and poisonings and cardiovascular disease. Mortality due to
 54   II,     5.  5.  3|                 disease. Mortality due to cardiovascular disease was more pronounced
 55   II,     5.  5.  3|                  etc. –, the high rate of cardiovascular and metabolic co-morbidities
 56   II,     5.  5.  3|                  obstetric complications, cardiovascular diseases, overweight, diabetes,
 57   II,     5.  5.  3|                   somatic diseases of the cardiovascular system (due to the use of
 58   II,     5.  6.  3|                   and almost as common as cardiovascular conditions in those over
 59   II,     5.  6.  3|                  Co-morbidity, especially cardiovascular disease and hypertension;
 60   II,     5.  6.  4|                 with mental disorders and cardiovascular disorders. The relative
 61   II,     5.  6.  4|                  times more frequent than cardiovascular disorders as causes for
 62   II,     5.  7.  1|                 it amplifies the risk for cardiovascular complications. Independent
 63   II,     5.  7.  1|                 CKD have a death risk for cardiovascular complications which is 2-
 64   II,     5.  7.  1|             progression and the resulting cardiovascular complications (Chobanian
 65   II,     5.  7.  1|                 frequent in patients with cardiovascular diseases where it acts as
 66   II,     5.  7.  1|                  CKD, its contribution to cardiovascular risk and to other diseases
 67   II,     5.  7.  1|                hypertension, diabetes and cardiovascular diseases are magnified by
 68   II,     5.  7.  1|                  also help to control the cardiovascular burden deriving from these
 69   II,     5.  7.  1|               these diseases. Even though cardiovascular diseases largely remain
 70   II,     5.  7.  3|                 similar, hypertension and cardiovascular mortality in the populations
 71   II,     5.  7.  4|           so-called competing risks (e.g. cardiovascular mortality in the general
 72   II,     5.  7.  5|                Targeting individuals with cardiovascular risk factors or with cardiovascular
 73   II,     5.  7.  5|       cardiovascular risk factors or with cardiovascular disease (i.e. those individuals
 74   II,     5.  7.  5|                 public health policies on cardiovascular disease and diabetes mellitus.~·
 75   II,     5.  7.  5|                   framework of an ongoing cardiovascular prevention project of the
 76   II,     5.  7.  7|                  ACE inhibitor to prevent cardiovascular events: a pharmacoeconomic
 77   II,     5.  7.  7|               Wheeler D (2000): Premature cardiovascular disease in chronic renal
 78   II,     5.  7.  7|                  PE (2005): The kidney, a cardiovascular risk marker, and a new target
 79   II,     5.  7.  7|                   and the risks of death, cardiovascular events, and hospitalization.
 80   II,     5.  7.  7|              infarction and all-cause and cardiovascular disease mortality in middle-aged
 81   II,     5.  7.  7|                 factor for development of cardiovascular disease: a statement from
 82   II,     5.  7.  7|         Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure
 83   II,     5.  8.Acr|         obstructive pulmonary disease~CVD~cardiovascular disease~ECRHS~European Community
 84   II,     5.  8.  3|                relevant association among cardiovascular disease, lung cancer, asthma
 85   II,     5.  8.  3|                 al, 2006). In this study, cardiovascular disease, ischemic heart
 86   II,     5.  8.  3|         certificate than when it was not. Cardiovascular disease (CVD) was described
 87   II,     5.  8.  4|                   interventions for acute cardiovascular diseases, and acute infections,
 88   II,     5.  8.  7|                   COPD) a Risk Factor for Cardiovascular Events? COPD: Journal of
 89   II,     5.  8.  7|              Eisner MD. COPD and incident cardiovascular disease hospitalizations
 90   II,     5. 11.  3|                 is true for a spectrum of cardiovascular, pulmonary and~digestive
 91   II,     5. 12.  3|                  failure (as well as from cardiovascular conditions) in subjects
 92   II,     5. 13    |          associated with risk factors for cardiovascular disease and diabetes, orthopaedic
 93   II,     5. 13    |                 adult mortality rates and cardiovascular disease, even if the excess
 94   II,     5. 14.  1|                especially with respect to cardiovascular and respiratory disorder,
 95   II,     5. 14.  3|             progression of diabetes, some cardiovascular diseases and the risk of
 96   II,     5. 14.  4|                such as obesity, diabetes, cardiovascular diseases, cancer, osteoporosis
 97   II,     7.  1    |                the EU Member States after cardiovascular diseases, cancer and respiratory
 98   II,     7.  3.  2|                  of death in the EU. Only cardiovascular diseases, cancer and diseases
 99   II,     8.  2.  1|             disorders, and lower rates of cardiovascular fitness, vaccination levels,
100   II,     9        |             significant proportion of the cardiovascular deaths in Eastern European
101   II,     9.  1.  2|                acid in protecting against cardiovascular disease, an additional argument
102   II,     9.  2.  1|                   high blood pressure and cardiovascular diseases.~ ~The consequences
103   II,     9.  3.  1|         predominant causes of death being cardiovascular diseases, cancer, accidents,
104   II,     9.  3.  1|               symptoms, type and onset of cardiovascular disease;~· response to toxins;~·
105   II,     9.  3.  1|                 have an increased risk of cardiovascular disease, cancer, suicide,
106   II,     9.  3.  1|                   of 65) is due mainly to cardiovascular diseases, cancer and injury
107   II,     9.  3.  1|                    Circulatory diseases~ ~Cardiovascular diseases are the main group
108   II,     9.  3.  1|           mortality and morbidity data of cardiovascular diseases are described in
109   II,     9.  3.  1|                more likely to suffer from cardiovascular disease (European Men’s
110   II,     9.  3.  1|                that deaths as a result of cardiovascular disease among men increased
111   II,     9.  3.  1|                 44 age group. Analysis of cardiovascular diseases highlighted the
112   II,     9.  3.  1|              sudden cardiac death.~ ~Most cardiovascular related deaths in the young
113   II,     9.  3.  1|             significant proportion of the cardiovascular deaths in Eastern European
114   II,     9.  3.  1|              relation between alcohol and cardiovascular disease in Eastern Europe:
115   II,     9.  4.  3|              Depression and Suicide: Only cardiovascular disease has a greater toll
116   II,     9.  4.  3|      non-communicable diseases, including cardiovascular diseases and cancers, can
117   II,     9.  4.  7|                  risk from all causes and cardiovascular and non-cardiovascular disease?
118   II,     9.  5.  1|                 symptoms and treatment of cardiovascular diseases vary between the
119   II,     9.  5.  1|                reduction has been seen in cardiovascular disease mortalityprimarily
120   II,     9.  5.  3|                   to increase the risk of cardiovascular disease and affect reproductive
121   II,     9.  5.  4|               major disease areas such as cardiovascular disease, cancer, diabetes
122   II,     9.  5.  4|           relevant to gender research are cardiovascular diseases - e.g. acute coronary
123  III,    10.  1    |                 sunlight)~radon~dioxins~ ~Cardiovascular diseases~air pollution (
124  III,    10.  1.  1|                 and ill-health, including cardiovascular disease and other chronic
125  III,    10.  1.  1|              behavioural risk factors for cardiovascular and other chronic diseases.
126  III,    10.  1.  3|                   in Children, Council on Cardiovascular Disease in the Young, American
127  III,    10.  1.  3|            Physical activity); Council on Cardiovascular Disease in the Young; and
128  III,    10.  2.  1|        obstructive pulmonary disease.~CVD~Cardiovascular disease.~DALY~Disability
129  III,    10.  2.  1|                 are fatal. Cancers (43%), cardiovascular diseases (28%) and respiratory
130  III,    10.  2.  1|                and adverse health effects~Cardiovascular diseases and adverse health
131  III,    10.  2.  1|                burden of chronic illness.~Cardiovascular disease (CVD) is the largest
132  III,    10.  2.  1|           significantly to mortality from cardiovascular diseases. It has a synergistic
133  III,    10.  2.  1|               with other risk factors for cardiovascular disease, such as high cholesterol
134  III,    10.  2.  1|                  The association with the cardiovascular disease is not unequivocally
135  III,    10.  2.  1|                   are often the result of cardiovascular and neurological problems
136  III,    10.  2.  1|                  diet. Some of them (i.e. cardiovascular diseases, cancer and diabetes)
137  III,    10.  2.  1|          associated with risk factors for cardiovascular disease and diabetes, orthopaedic
138  III,    10.  2.  1|                 adult mortality rates and cardiovascular disease, even if the excess
139  III,    10.  2.  1|                 deficiencies also promote cardiovascular disease, mental disturbances
140  III,    10.  2.  1|                  to an increased risk for cardiovascular diseases.~Surveys have shown
141  III,    10.  2.  1|        Considering the high prevalence of cardiovascular diseases in Europe that
142  III,    10.  2.  1|          infections, male infertility and cardiovascular diseases (Brown & Arthur,
143  III,    10.  2.  1|             diet-related diseases such as cardiovascular disease, diabetes and osteoporosis.
144  III,    10.  2.  1|          estimated prevalence of selected cardiovascular and related diseases. Croatian
145  III,    10.  2.  4|                causation of diseases like cardiovascular diseases , allergies, cancer,
146  III,    10.  2.  4|                and alcohol on the risk of cardiovascular diseases and dementia or
147  III,    10.  3.  1|          leukaemia. For breast cancer and cardiovascular disease, recent research
148  III,    10.  3.  1|                 and all its consequences, cardiovascular effects, hormonal responses,
149  III,    10.  3.  1|            elevated relative risks to the cardiovascular, respiratory and musculo-skeletal
150  III,    10.  3.  1|          annoyance, sleep disturbance and cardiovascular disease due to noise exposure
151  III,    10.  3.  1|                several health end-points: cardiovascular disease, cognitive impairment
152  III,    10.  3.  1|              associated with an increased cardiovascular risk. Several epidemiological
153  III,    10.  3.  1|                 to adverse effects on the cardiovascular system such as increased
154  III,    10.  3.  1|                  Transportation noise and cardiovascular risk. Review and synthesis
155  III,    10.  3.  1|                    Road traffic noise and cardiovascular risk. Noise Health 10(38),
156  III,    10.  3.  2|                 sunlight)~radon~dioxins~ ~Cardiovascular diseases~air pollution (
157  III,    10.  3.  4|                been further attributed to cardiovascular and respiratory diseases.
158  III,    10.  3.  4|               more at risk. These include cardiovascular diseases, respiratory insufficiency,
159  III,    10.  4.  1|                   hospital admissions for cardiovascular and respiratory symptoms.
160  III,    10.  4.  1|            suffering from respiratory and cardiovascular diseases.~ ~The loss of
161  III,    10.  4.  1|                      Respiratory (PM,O3); Cardiovascular (PM)~o Days of restricted
162  III,    10.  4.  3|                 been documented to induce cardiovascular diseases and probably also
163  III,    10.  5.  1|                     In addition to having cardiovascular effects, excessive noise
164  III,    10.  5.  1|                 number of respiratory and cardiovascular deaths, as the example of
165  III,    10.  5.  1|                  by 15.5% and deaths from cardiovascular causes decreased by 10.3% (
166  III,    10.  5.  3|            diseases but are available for cardiovascular diseases (CVD) as well as
167  III,    10.  5.  3|        work-related stress also increases cardiovascular mortality. These issues
168  III,    10.  5.  3|              stress, which also increases cardiovascular mortality.~In industrialised
169  III,    10.  5.  3|                times increase the risk of cardiovascular diseases.~ ~Consequences
170  III,    10.  5.  3|                   public health report on cardiovascular diseases and mental ill
171  III,    10.  5.  3|                 2005): Economic burden of cardiovascular diseases in the enlarged
172  III,    10.  6.  1|                  from all causes and from cardiovascular disease: prospective evidence
173  III,    10.  6.  2|                causes of death, including cardiovascular disease, many types of cancers,
174  III,    10.  6.  2|                   showed that, in the EU, cardiovascular diseases are the main causes
175  III,    10.  6.  2|             faster mortality declines for cardiovascular diseases. In many Western
176  III,    10.  6.  2|               substantial improvements in cardiovascular disease mortality. This
177   IV,    11.  2.  1|                   most commonly diabetes, cardiovascular disease and cancer. A review
178   IV,    11.  6.  4|                   phase, orthopaedics and cardiovascular disease and surgery were
179   IV,    11.  6.  4|                  provide information.~The cardiovascular pilot defined a simple set
180   IV,    12.  2    |               tools for selected diseases~Cardiovascular diseases (CVD)~ ~Blood lipid
181   IV,    12.  2    |              Presidency note on promoting cardiovascular health in the Health Council
182   IV,    12.  2    |              action is taken on promoting cardiovascular health, emphasize the importance
183   IV,    12. 10    |                   second one is starting) cardiovascular diseases, asthma, diabetes,
184   IV,    12. 10    |                 address the prevention of cardiovascular risk.~National Prevention
185   IV,    12. 10    |          non-communicable diseases, incl. cardiovascular diseases” in national Public
186   IV,    12. 10    |                 Prevention and Control of Cardiovascular Diseases~Interactions amongst
187   IV,    12. 10    |                   programs (prevention of cardiovascular diseases, screening for
188   IV,    12. 10    |        determinants~ low~Determinants for cardiovascular diseases~ Media campaign~ ~ ~
189   IV,    13.  2.  3|                  combined (2) ,~Smoking~ ~Cardiovascular diseases, all cancers~100,
190   IV,    13.  2.  3|                  together, in relation to cardiovascular diseases and the relevant
191   IV,    13.  2.  3|                   alcohol consumptions on cardiovascular diseases, diabetes mellitus
192   IV,    13.  2.  3|                   two for women) prevents cardiovascular diseases, as compared to
193   IV,    13.  5    |                   the fight against adult cardiovascular disease, alcohol and tobacco
194   IV,    13.  7.  3|             fields of genomics, oncology, cardiovascular medicine, virology, and
195  Key,   Ap5.  0.  0|             carcinogens~carcinoma~cardiac~cardiovascular~care giver~care givers~caries~